Del Fosse Franc 4
4 · Insys Therapeutics, Inc. · Filed Nov 21, 2017
Insider Transaction Report
Form 4
Del Fosse Franc
General Counsel
Transactions
- Award
Stock Option (right to buy)
2017-11-17+25,000→ 25,000 totalExercise: $5.37Exp: 2027-11-16→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option shall vest in 36 equal monthly installments until fully vested and exercisable on November 17, 2020.